Company intelligence / Profile preview

YOFiMeter

Ownership: Private
Development stage: Commercial

Overview

YOFiMeter is a commercial digital health device and software platform for diabetes management. It allows users to log blood glucose, carbohydrate intake, insulin and medication usage, physical activity, and other relevant data. The system includes a web-based or smartphone-accessible account called "YOFiShare" for data tracking and sharing with healthcare providers or caregivers. No clinical trial results are referenced; the product is marketed directly to consumers as a self-management tool.

Therapeutic areas: Endocrinology
Modalities: DeviceDigital health platform
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on YOFiMeter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YOFiMeter.

Explore the full profile